Subtype of lethal prostate cancer discoveredThe loss of key gene, WAVE1 has been linked by researchers to a lethal form of prostate cancer, according to a study. Using bioinformatic meta-analysis to compare several publicly available databases, researchers found that alterations in the WAVE1 gene were associated with a shorter period of remission in patients who were treated for prostate cancer.
Breakthrough finds molecules that block previously 'undruggable' protein tied to cancer New findings on HuR, an 'oncoprotein,' hold promise for treating every type of cancer tested, including cancers of the colon, prostate, breast, brain, ovaries, pancreas and lung, scientists report, adding that the findings could lead to a new class of cancer drugs.
Uncovering genetic diversity of pancreatic cancer Most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment. The findings support a precision approach to treating pancreatic cancer, the fourth most deadly cancer for both men and women
Study on new treatment for prostate cancer A new study represents the first time low temperature plasmas (LTPs) have been applied on cells grown directly from patient tissue samples. Taking both healthy prostate cells and prostate cancer tissue cells from a single patient, the study allowed for direct comparison of the effectiveness of the treatment. Scientists discovered that LTPs may be a potential option for treatment of patients with organ confined prostate cancer, and a viable, more cost-effective alternative to current radiotherapy and photodynamic therapy treatments